Development
Tenet Healthcare Corporation
THC
$172.02
-$0.34-0.20%
NYSE
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 6.18% | -0.31% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.18% | -0.31% | |||
| Cost of Revenue | 2.59% | -0.38% | |||
| Gross Profit | 12.16% | -0.21% | |||
| SG&A Expenses | 301.92% | 0.97% | |||
| Depreciation & Amortization | -3.57% | 5.16% | |||
| Other Operating Expenses | -34.62% | -1.37% | |||
| Total Operating Expenses | 0.87% | -0.31% | |||
| Operating Income | 48.58% | -0.35% | |||
| Income Before Tax | 50.43% | -7.51% | |||
| Income Tax Expenses | -20.25% | -1.25% | |||
| Earnings from Continuing Operations | 71.43% | -9.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -28.48% | 2.94% | |||
| Net Income | 141.58% | -17.89% | |||
| EBIT | 48.58% | -0.35% | |||
| EBITDA | 33.76% | 1.16% | |||
| EPS Basic | 143.00% | -17.71% | |||
| Normalized Basic EPS | 178.98% | -0.55% | |||
| EPS Diluted | 145.50% | -18.06% | |||
| Normalized Diluted EPS | 178.05% | -0.43% | |||
| Average Basic Shares Outstanding | -0.58% | -0.22% | |||
| Average Diluted Shares Outstanding | -0.25% | -0.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||